Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang+4 more
wiley +1 more source
Correction: A2B Adenosine Receptor Expression by Myeloid Cells is Proinflammatory in Murine Allergic-Airway Inflammation. [PDF]
Belikoff BG+3 more
europepmc +1 more source
High-throughput transcriptome sequencing reveals the protective role of adenosine receptor-related genes in paraquat-exposed Caenorhabditis elegans. [PDF]
Ma L, Ling C, Hu S, Ye S, Chen C.
europepmc +1 more source
Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor [PDF]
M.V. Patel+2 more
openalex +1 more source
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders. [PDF]
Francucci B+9 more
europepmc +1 more source
Evidence for deactivation of both ectosolic and cytosolic 5'-nucleotidase by adenosine A1 receptor activation in the rat cardiomyocytes. [PDF]
Masafumi Kitakaze+9 more
openalex +1 more source
A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants. [PDF]
Gupta P+9 more
europepmc +1 more source
Binding characteristics of an adenosine receptor in human placenta
Theodore A. Alston+2 more
openalex +1 more source